Evidence map›Paper›PMID 32110361›Full record

ArticleChemical science2020

Enantioselective synthesis of

Ren-Yi Zhu, Long Chen, Xiao-Si Hu, Feng Zhou, Jian Zhou

Abstract read
In one paragraph

Article in Chemical science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Sulfonyl-PYBOX/ErClNature communications · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ren-Yi ZhuShanghai Engineering Research Center of Molecular Therapeutics and New Drug Development , China . Email: jzhou@chem.ecnu.edu.cn.
Long ChenShanghai Engineering Research Center of Molecular Therapeutics and New Drug Development , China . Email: jzhou@chem.ecnu.edu.cn.
Xiao-Si HuShanghai Engineering Research Center of Molecular Therapeutics and New Drug Development , China . Email: jzhou@chem.ecnu.edu.cn.
Feng ZhouShanghai Engineering Research Center of Molecular Therapeutics and New Drug Development , China . Email: jzhou@chem.ecnu.edu.cn.ORCID 0000-0002-6729-1311
Jian ZhouShanghai Engineering Research Center of Molecular Therapeutics and New Drug Development , China . Email: jzhou@chem.ecnu.edu.cn.ORCID 0000-0003-0679-6735

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the highly enantioselective synthesis of

Identifiers

PMID32110361
PMCPMC7012078

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.